Fibromyalgia as a Predictor of Increased Postoperative Complications, Readmission Rates, and Hospital Costs in Patients Undergoing Posterior Lumbar Spine Fusion

Chester J. Donnally, Rushabh M. Vakharia, Augustus J. Rush, Dhanur Damodar, Ajit J. Vakharia, Vadim Goz, Nathan H. Lebwohl

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

STUDY DESIGN: Retrospective review. OBJECTIVE: The aim of this study was to identify whether a concomitant diagnosis of fibromyalgia (FM) influences postoperative complications, readmission rates or cost following primary 1 to 2 level lumbar fusions in an elective setting. SUMMARY OF BACKGROUND DATA: Patients with FM often are limited by chronic lower back pain, many of whom will seek operative treatment. No previous study has evaluated whether patients with a concomitant diagnosis of FM have more complications following spine surgery. METHODS: Medicare data (2005-2014) from a national database was queried for patients who underwent primary 1 to 2 level posterolateral lumbar spine fusion for degenerative lumbar pathology. Thirty- and 90-day postoperative complication rates, readmission rates, and treatment costs were queried. To reduce confounding, FM patients were matched with a control cohort of non-FM patients using patient demographics, treatment modality, and comorbid conditions, and then analyzed by multivariable logistic regression. RESULTS: Within the first 30-day postoperative, acute post hemorrhagic anemia (odds ratio [OR]: 2.58; P < 0.001) and readmission rates were significantly higher in FM patients compared to controls. There was no significant difference in wound related complications within first 30-days (0.19% vs. 0.23%; P = 0.520) or with length of stay (3.60 vs. 3.53 days; P = 0.08). Within 90-day postoperative, FM patients had higher rates of pneumonia (OR: 3.73; P < 0.001) and incurred 5.31% more in hospital charges reimbursed compared to the control cohort. CONCLUSION: Primary 1 to 2 level lumbar fusions performed on FM patients have higher rates of postoperative anemia, pneumonia, cost of care, and readmission compared to match controls. FM patients and surgeons should be aware of these increased risks in an effort to control hospital costs and potential complications.3.

Original languageEnglish (US)
Pages (from-to)E233-E238
JournalSpine
Volume44
Issue number4
DOIs
StatePublished - Feb 15 2019

Fingerprint

Fibromyalgia
Hospital Costs
Spine
Anemia
Pneumonia
Odds Ratio
Hospital Charges
Costs and Cost Analysis
Medicare
Low Back Pain
Health Care Costs
Length of Stay
Logistic Models
Demography
Databases
Pathology

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Clinical Neurology

Cite this

Fibromyalgia as a Predictor of Increased Postoperative Complications, Readmission Rates, and Hospital Costs in Patients Undergoing Posterior Lumbar Spine Fusion. / Donnally, Chester J.; Vakharia, Rushabh M.; Rush, Augustus J.; Damodar, Dhanur; Vakharia, Ajit J.; Goz, Vadim; Lebwohl, Nathan H.

In: Spine, Vol. 44, No. 4, 15.02.2019, p. E233-E238.

Research output: Contribution to journalArticle

Donnally, Chester J. ; Vakharia, Rushabh M. ; Rush, Augustus J. ; Damodar, Dhanur ; Vakharia, Ajit J. ; Goz, Vadim ; Lebwohl, Nathan H. / Fibromyalgia as a Predictor of Increased Postoperative Complications, Readmission Rates, and Hospital Costs in Patients Undergoing Posterior Lumbar Spine Fusion. In: Spine. 2019 ; Vol. 44, No. 4. pp. E233-E238.
@article{8a2878e4700c4a5ab5da6afa2fb07a7e,
title = "Fibromyalgia as a Predictor of Increased Postoperative Complications, Readmission Rates, and Hospital Costs in Patients Undergoing Posterior Lumbar Spine Fusion",
abstract = "STUDY DESIGN: Retrospective review. OBJECTIVE: The aim of this study was to identify whether a concomitant diagnosis of fibromyalgia (FM) influences postoperative complications, readmission rates or cost following primary 1 to 2 level lumbar fusions in an elective setting. SUMMARY OF BACKGROUND DATA: Patients with FM often are limited by chronic lower back pain, many of whom will seek operative treatment. No previous study has evaluated whether patients with a concomitant diagnosis of FM have more complications following spine surgery. METHODS: Medicare data (2005-2014) from a national database was queried for patients who underwent primary 1 to 2 level posterolateral lumbar spine fusion for degenerative lumbar pathology. Thirty- and 90-day postoperative complication rates, readmission rates, and treatment costs were queried. To reduce confounding, FM patients were matched with a control cohort of non-FM patients using patient demographics, treatment modality, and comorbid conditions, and then analyzed by multivariable logistic regression. RESULTS: Within the first 30-day postoperative, acute post hemorrhagic anemia (odds ratio [OR]: 2.58; P < 0.001) and readmission rates were significantly higher in FM patients compared to controls. There was no significant difference in wound related complications within first 30-days (0.19{\%} vs. 0.23{\%}; P = 0.520) or with length of stay (3.60 vs. 3.53 days; P = 0.08). Within 90-day postoperative, FM patients had higher rates of pneumonia (OR: 3.73; P < 0.001) and incurred 5.31{\%} more in hospital charges reimbursed compared to the control cohort. CONCLUSION: Primary 1 to 2 level lumbar fusions performed on FM patients have higher rates of postoperative anemia, pneumonia, cost of care, and readmission compared to match controls. FM patients and surgeons should be aware of these increased risks in an effort to control hospital costs and potential complications.3.",
author = "Donnally, {Chester J.} and Vakharia, {Rushabh M.} and Rush, {Augustus J.} and Dhanur Damodar and Vakharia, {Ajit J.} and Vadim Goz and Lebwohl, {Nathan H.}",
year = "2019",
month = "2",
day = "15",
doi = "10.1097/BRS.0000000000002820",
language = "English (US)",
volume = "44",
pages = "E233--E238",
journal = "Spine",
issn = "0362-2436",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Fibromyalgia as a Predictor of Increased Postoperative Complications, Readmission Rates, and Hospital Costs in Patients Undergoing Posterior Lumbar Spine Fusion

AU - Donnally, Chester J.

AU - Vakharia, Rushabh M.

AU - Rush, Augustus J.

AU - Damodar, Dhanur

AU - Vakharia, Ajit J.

AU - Goz, Vadim

AU - Lebwohl, Nathan H.

PY - 2019/2/15

Y1 - 2019/2/15

N2 - STUDY DESIGN: Retrospective review. OBJECTIVE: The aim of this study was to identify whether a concomitant diagnosis of fibromyalgia (FM) influences postoperative complications, readmission rates or cost following primary 1 to 2 level lumbar fusions in an elective setting. SUMMARY OF BACKGROUND DATA: Patients with FM often are limited by chronic lower back pain, many of whom will seek operative treatment. No previous study has evaluated whether patients with a concomitant diagnosis of FM have more complications following spine surgery. METHODS: Medicare data (2005-2014) from a national database was queried for patients who underwent primary 1 to 2 level posterolateral lumbar spine fusion for degenerative lumbar pathology. Thirty- and 90-day postoperative complication rates, readmission rates, and treatment costs were queried. To reduce confounding, FM patients were matched with a control cohort of non-FM patients using patient demographics, treatment modality, and comorbid conditions, and then analyzed by multivariable logistic regression. RESULTS: Within the first 30-day postoperative, acute post hemorrhagic anemia (odds ratio [OR]: 2.58; P < 0.001) and readmission rates were significantly higher in FM patients compared to controls. There was no significant difference in wound related complications within first 30-days (0.19% vs. 0.23%; P = 0.520) or with length of stay (3.60 vs. 3.53 days; P = 0.08). Within 90-day postoperative, FM patients had higher rates of pneumonia (OR: 3.73; P < 0.001) and incurred 5.31% more in hospital charges reimbursed compared to the control cohort. CONCLUSION: Primary 1 to 2 level lumbar fusions performed on FM patients have higher rates of postoperative anemia, pneumonia, cost of care, and readmission compared to match controls. FM patients and surgeons should be aware of these increased risks in an effort to control hospital costs and potential complications.3.

AB - STUDY DESIGN: Retrospective review. OBJECTIVE: The aim of this study was to identify whether a concomitant diagnosis of fibromyalgia (FM) influences postoperative complications, readmission rates or cost following primary 1 to 2 level lumbar fusions in an elective setting. SUMMARY OF BACKGROUND DATA: Patients with FM often are limited by chronic lower back pain, many of whom will seek operative treatment. No previous study has evaluated whether patients with a concomitant diagnosis of FM have more complications following spine surgery. METHODS: Medicare data (2005-2014) from a national database was queried for patients who underwent primary 1 to 2 level posterolateral lumbar spine fusion for degenerative lumbar pathology. Thirty- and 90-day postoperative complication rates, readmission rates, and treatment costs were queried. To reduce confounding, FM patients were matched with a control cohort of non-FM patients using patient demographics, treatment modality, and comorbid conditions, and then analyzed by multivariable logistic regression. RESULTS: Within the first 30-day postoperative, acute post hemorrhagic anemia (odds ratio [OR]: 2.58; P < 0.001) and readmission rates were significantly higher in FM patients compared to controls. There was no significant difference in wound related complications within first 30-days (0.19% vs. 0.23%; P = 0.520) or with length of stay (3.60 vs. 3.53 days; P = 0.08). Within 90-day postoperative, FM patients had higher rates of pneumonia (OR: 3.73; P < 0.001) and incurred 5.31% more in hospital charges reimbursed compared to the control cohort. CONCLUSION: Primary 1 to 2 level lumbar fusions performed on FM patients have higher rates of postoperative anemia, pneumonia, cost of care, and readmission compared to match controls. FM patients and surgeons should be aware of these increased risks in an effort to control hospital costs and potential complications.3.

UR - http://www.scopus.com/inward/record.url?scp=85061140923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061140923&partnerID=8YFLogxK

U2 - 10.1097/BRS.0000000000002820

DO - 10.1097/BRS.0000000000002820

M3 - Article

C2 - 30059488

AN - SCOPUS:85061140923

VL - 44

SP - E233-E238

JO - Spine

JF - Spine

SN - 0362-2436

IS - 4

ER -